Compounds > molybdenum
Page last updated: 2024-08-22

molybdenum and Squamous Cell Carcinoma of Head and Neck

molybdenum has been researched along with Squamous Cell Carcinoma of Head and Neck in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Li, H; Li, J; Liu, M; Liu, T; Tu, Z; Wen, W; Xie, X; Zhang, S; Zhu, Y1
Akiyama, K; Hasegawa, K; Ibaragi, S; Kishimoto, K; Kunisada, Y; Monsur Hassan, NM; Okui, T; Ryumon, S; Sasaki, A; Shimo, T; Thu Ha, NT1
Hassan, NMM; Ibaragi, S; Morisawa, A; Nguyen, TTH; Okui, T; Okusha, Y; Ono, M; Sasaki, A; Shimo, T1

Other Studies

3 other study(ies) available for molybdenum and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Construction of CpG Delivery Nanoplatforms by Functionalized MoS
    Small (Weinheim an der Bergstrasse, Germany), 2023, Volume: 19, Issue:41

    Topics: Cytokines; Head and Neck Neoplasms; Humans; Immunotherapy; Molybdenum; Squamous Cell Carcinoma of Head and Neck; Tumor Microenvironment

2023
Ammonium tetrathiomolybdate enhances the antitumor effect of cisplatin via the suppression of ATPase copper transporting beta in head and neck squamous cell carcinoma.
    Oncology reports, 2019, Volume: 42, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cisplatin; Copper-Transporting ATPases; Drug Resistance, Neoplasm; Drug Synergism; Head and Neck Neoplasms; Humans; Male; Mice; Molybdenum; Squamous Cell Carcinoma of Head and Neck; Tissue Array Analysis; Xenograft Model Antitumor Assays

2019
Ammonium tetrathiomolybdate enhances the antitumor effects of cetuximab via the suppression of osteoclastogenesis in head and neck squamous carcinoma.
    International journal of oncology, 2018, Volume: 52, Issue:3

    Topics: Animals; Antineoplastic Agents, Immunological; Bone Neoplasms; Bone Resorption; Carcinoma, Squamous Cell; Cetuximab; Chelating Agents; Copper; Drug Synergism; Female; Head and Neck Neoplasms; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Molybdenum; Neoplasm Invasiveness; Osteoclasts; Protein-Lysine 6-Oxidase; RANK Ligand; Squamous Cell Carcinoma of Head and Neck; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2018